Effects of Self-Made Prescription Compound Rhodiola on the Ultrastructure of Podocytes in Rats with Type 2 Diabetic Nephropathy
Authors:
Open Access
- 22 June 2022
- journal article
- retracted article
- Published by Hindawi Limited in Emergency Medicine International
- Vol. 2022, 1-7
Abstract
Background. We attempt to discuss the function of self-made prescription compound Rhodiola rosea on the kidneys of rats with type 2 diabetic nephropathy (DN), through studying the effects of self-made rescription compound Rhodiola rosea on the ultrastructure of podocytes in rats with DN. Methods. DN rat model was established by streptozotocin. The successfully modeled rats were divided into 4 groups, DN group, compound Rhodiola low-dose group, medium-dose group, and high-dose group. Compound Rhodiola low-dose group, medium-dose group, and high-dose group were administered for 8 weeks, and the DN group and the blank control group were administered with normal saline. The podocyte count, podocyte width, podocyte fusion rate, and average thickness of glomerular basement membrane were compared in each group, and the ultrastructural changes in podocytes were observed by transmission electron microscope. Results. Compared with the normal control group, the number of podocytes in the DN group remarkably reduced, but the width level of podocyte, the fusion rate of podocyte, and the average thickness of basilar membrane remarkably increased ( ). Compared with the DN group, the number of podocytes in the high-, medium-, and low-dose groups increased remarkably, but the width level of podocyte, the fusion rate of podocyte, and the average thickness of basilar membrane decreased remarkably ( ). Compared with the low-dose group, the number of podocytes in the high-dose group and the medium-dose group increased remarkably, but the width of podocyte, the fusion rate of podocyte, as well as the average thickness of basilar membrane remarkably reduced ( ). Various indicators of high- and medium-dose groups had no statistical difference ( ). Conclusions. Self-made prescription compound Rhodiola rosea can promote the recovery of podocyte in DN rat and protect their kidney.Keywords
This publication has 18 references indexed in Scilit:
- Salidroside stimulates the Sirt1/PGC-1α axis and ameliorates diabetic nephropathy in micePhytomedicine, 2019
- Glomerular mesangial cell and podocyte injuries in diabetic nephropathyNephrology, 2018
- Update of pathophysiology and management of diabetic kidney diseaseJournal of the Formosan Medical Association, 2018
- Epidemiology of diabetes and diabetic complications in ChinaDiabetologia, 2018
- Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathwayChemico-Biological Interactions, 2017
- Rhodiola rosea L.: an Herb with Anti-Stress, Anti-Aging, and Immunostimulating Properties for Cancer ChemopreventionCurrent Pharmacology Reports, 2017
- Effect of ethanol extract of Rhodiola rosea on the early nephropathy in type 2 diabetic ratsCurrent Medical Science, 2013
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Identifying Individuals at High Risk for DiabetesDiabetes Care, 2005
- Evidence of apoptosis in human diabetic kidneyMolecular and Cellular Biochemistry, 2004